G7 announces pledges of 870 million COVID-19 vaccine doses, of which at least half to be delivered by the end of 2021
- COVAX welcomes dose sharing
commitments for 870 million additional doses to support equitable access to vaccines
in 2021 and 2022, with the aim to deliver at least half by the end of 2021.
- The G7 has committed one billion
doses since the February 2021 virtual G7 Early Leaders’ Summit, including
pledges made at the G20 Global Health Summit hosted by Prime Minister Draghi
and President von der Leyen and the Gavi COVAX AMC Summit hosted by Prime
Minister Yoshihide Suga of Japan.
- COVAX partners applaud G7 leaders’
support for global public health.
In a landmark agreement at the G7
summit, held in Cornwall, the United Kingdom of Great Britain and Northern
Ireland, global leaders have pledged to share COVID-19 vaccine doses
internationally, in support of global equitable access and to help end the
acute phase of the pandemic.
Building on the momentum of the G20
Global Health Summit hosted by Prime Minister Draghi and President von der
Leyen and the Gavi COVAX AMC Summit hosted by Prime Minister Yoshihide Suga of
Japan, G7 countries committed to share at least 870 million doses of COVID-19
vaccines directly, with the aim to deliver at least half by the end of 2021,
and reaffirmed their support for COVAX as “the primary route for providing
vaccines to the poorest countries.”
COVAX partners welcome this
commitment, along with continued support for exporting in significant
proportions, promotion of voluntary licensing and not-for-profit global
production. COVAX looks forward to seeing doses flowing to countries as soon as
possible. Facing an urgent supply gap, COVAX is focused on securing as many
shared doses as possible immediately, as the third quarter of this year is when
the gap between deliveries and countries’ ability to absorb doses will be
greatest. COVAX will work with the G7 and other countries that have stepped up
to share doses as rapidly and equitably as possible. This will help address
short-term supply constraints currently impacting the global response to
COVID-19 and minimize the prospect of future deadly variants.
In anticipation of the large
volumes available through the COVAX Facility deals portfolio later in the year,
COVAX also urges multilateral development banks to urgently release funding to
help countries prepare their health systems for large-scale rollout of vaccines
in the coming months.
“This is an
important moment of global solidarity and a critical milestone in the push to
ensure those most at risk, everywhere are protected,” said Dr Seth Berkley, CEO
of Gavi, the Vaccine Alliance (Gavi). “As we strive towards our goal of ending
the acute phase of the pandemic, we look forward to working with countries to
ensure these doses pledged are quickly turned into doses delivered.”
“This is an
historic moment - as leaders of some of the wealthiest counties come together
to ensure that all parts of the world have access to life saving vaccines,” Dr
Richard Hatchett, CEO of CEPI (the Coalition for Epidemic Preparedness
Innovations), added. “This pandemic has shown us that we cannot set national
against international interests. With a disease like COVID-19 we have to ensure
that we get it under control everywhere. There is still much to do to get
vaccines in arms and ensure our R&D allows us to stay one step ahead of the
virus. But for today we give pause and celebrate a watershed moment of
political alignment and collaboration.”
Henrietta Fore, Executive Director
of UNICEF, said: “We have reached a grim milestone in this pandemic: There are
already more dead from COVID-19 in 2021 than in all of last year. Without
urgent action, this devastation will continue. Equitable access to COVID-19
vaccines represents the clearest pathway out of this pandemic for all of us —
children included. UNICEF thanks G7 member states for their significant pledges
and continued support. However, much work remains to continue to ramp up both
the amount and the pace of supply to the rest of the world, because when it
comes to ending the COVID-19 pandemic, our best interests and our best natures
align. This crisis will not be over until it is over for everyone.”
WHO Director General, Dr Tedros
Adhanom Ghebreyesus, stressed: "Many other countries are now facing a
surge in cases – and they are facing it without vaccines. We are in the race of
our lives, but it’s not a fair race, and most countries have barely left the
starting line. We welcome the generous announcements about donations of
vaccines and thank leaders. But we need more, and we need them faster."
“Africa’s current vaccine supply shortage risks prolonging the pandemic, not just for millions on the continent, but for the whole world,” said Dr Githinji Gitahi, Group CEO, AMREF Health Africa. “I applaud the Group of Seven's leadership in sharing doses with COVAX and urge them - and others to share doses now, not later in the year, when our need is greatest.”
출처: World Health Organization